clinical development special k superbugsThis week, we continue looking into a very hot topic, Wearables, plus a tipping point in clinical trials and new developments in diabetes.

The debate continues over how to optimize clinical trials, with some experts calling for incremental changes to combat inefficiencies while the FDA’s deputy commissioner says the industry is at a “tipping point.”